Camp4 Therapeutics (CAMP) Non-Current Assets (2023 - 2026)
Camp4 Therapeutics (CAMP) posted Non-Current Assets of $3.3 million for Q1 2026, down 12.2% sequentially from $3.7 million in Q4 2025, and down 70.63% YoY from $11.1 million in Q1 2025.
Analysis
Camp4 Therapeutics (CAMP) Non-Current Assets (2023 - 2026) Analysis & Trends
Camp4 Therapeutics has reported Non-Current Assets for 4 years, with the latest figure at $3.3 million in Q1 2026.
- Quarterly Non-Current Assets fell 70.63% year-over-year to $3.3 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $25.8 million (down 51.97% YoY) and the FY2025 annual result came in at $3.7 million, down 68.86% from the prior year.
- Non-Current Assets fell to $3.3 million in Q1 2026 per CAMP's latest filing, from $3.7 million in the prior quarter.
- Over five years, Non-Current Assets peaked at $15.9 million in Q3 2024 and troughed at $3.3 million in Q1 2026.
- A 4-year average of $10.0 million and a median of $10.6 million in 2025 frame the typical range for Non-Current Assets.
- The sharpest annual moves came in 2024 and 2026: Non-Current Assets slipped 20.15% in 2024, then plunged 70.63% in 2026.
- Over 4 years, Non-Current Assets stood at $14.9 million in 2023, then retreated by 20.15% to $11.9 million in 2024, then sank by 68.86% to $3.7 million in 2025, then dropped by 12.2% to $3.3 million in 2026.
- According to Business Quant data, Non-Current Assets over the past three periods registered $3.3 million, $3.7 million, and $8.7 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn | 14.88 Bn |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn | 23.28 Bn |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn | 1.96 Bn |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn | 5.15 Bn |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - | 294.93 Mn |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn | 1.96 Bn |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn | 938.60 Mn |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - | 18.06 Bn |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | 468.65 Mn |
| 10 | Camp4 Therapeutics | 260.10 Mn | 260.10 Mn | - | 3.40 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 3.40 Mn |
| Mar 31, 2026 | 3.26 Mn |
| Dec 31, 2025 | 3.71 Mn |
| Sep 30, 2025 | 8.69 Mn |
| Jun 30, 2025 | 10.19 Mn |
| Mar 31, 2025 | 11.10 Mn |
| Dec 31, 2024 | 11.92 Mn |
| Sep 30, 2024 | 15.86 Mn |
| Dec 31, 2023 | 14.93 Mn |